UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Multiple Sclerosis: Current Knowledge and Future Outlook

European neurology, 2014-01, Vol.72 (3-4), p.132-141

2014

Volltextzugriff (PDF)

Digital health for chronic disease management: An exploratory method to investigating technology adoption potential

PloS one, 2023-04, Vol.18 (4), p.e0284477-e0284477

2023

Volltextzugriff (PDF)

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors

Frontiers in neurology, 2021-07, Vol.12, p.693440-693440

2021

Volltextzugriff (PDF)

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Journal of headache and pain, 2022-12, Vol.23 (1), p.161-161, Article 161

2022

Volltextzugriff (PDF)

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey

Frontiers in neurology, 2018-10, Vol.9, p.821-821

2018

Volltextzugriff (PDF)

60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments

Frontiers in neurology, 2020-03, Vol.11, p.156-156

2020

Volltextzugriff (PDF)

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis

Frontiers in neurology, 2019-09, Vol.10, p.953-953

2019

Volltextzugriff (PDF)

Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)

BMJ neurology open, 2023-01, Vol.5 (1), p.e000304-e000304

2023

Volltextzugriff (PDF)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Vaccines (Basel), 2022-06, Vol.10 (6), p.922

2022

Volltextzugriff (PDF)

Interdisciplinary Cardiovascular and Neurologic Outpatient Rehabilitation in Patients Surviving Transient Ischemic Attack or Stroke With Minor or No Residual Deficits

Archives of physical medicine and rehabilitation, 2014-04, Vol.95 (4), p.656-662

2014

Volltextzugriff (PDF)

The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis

Brain sciences, 2021-06, Vol.11 (6), p.751

2021

Volltextzugriff (PDF)

Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled Trial

Frontiers in neurology, 2019-02, Vol.10, p.61

2019

Volltextzugriff (PDF)

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

CNS neuroscience & therapeutics, 2022-06, Vol.28 (6), p.971-973

2022

Volltextzugriff (PDF)

Development of a new immersive virtual reality (VR) headset-based dexterity training for patients with multiple sclerosis: Clinical and technical aspects

Technology and health care, 2024-01, Vol.32 (2), p.1067

2024

Volltextzugriff (PDF)

Behavioral Changes in Patients with Multiple Sclerosis

Frontiers in neurology, 2017-08, Vol.8, p.437-437

2017

Volltextzugriff (PDF)

Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions

Seminars in neurology, 2016-04, Vol.36 (2), p.196

2016

Volltextzugriff (PDF)

Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results

Journal of neurology, 2024-08, Vol.271 (8), p.5402-5410

2024

Volltextzugriff (PDF)

Relationship between Job Demands‐Resources and turnover intention in chronic disease – The example of multiple sclerosis

Stress and health, 2021-12, Vol.37 (5), p.940-948

2021

Volltextzugriff (PDF)

Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?

Journal of psychosomatic research, 2021-05, Vol.144, p.110402-110402, Article 110402

2021

Volltextzugriff (PDF)

Hypomagnesemia-Induced Cerebellar Syndrome—A Distinct Disease Entity? Case Report and Literature Review

Frontiers in neurology, 2020-09, Vol.11

2020

Volltextzugriff (PDF)

Tablet app-based dexterity training in multiple sclerosis (TAD-MS): a randomized controlled trial

Disability and rehabilitation: Assistive technology, 2024-04, Vol.ahead-of-print (ahead-of-print), p.1-11

2024

Volltextzugriff (PDF)

Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries

Multiple sclerosis, 2021-01, Vol.27 (1), p.90-96

2021

Volltextzugriff (PDF)

SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology

Trials, 2009-12, Vol.10 (1), p.115-115, Article 115

2009

Volltextzugriff (PDF)

T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter

Scientific reports, 2018-11, Vol.8 (1), p.16844-8, Article 16844

2018

Volltextzugriff (PDF)

Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry

Multiple sclerosis and related disorders, 2023-01, Vol.69, p.104438-104438, Article 104438

2023

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(58)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multiple Sclerosis: Current Knowledge and Future Outlook

Digital health for chronic disease management: An exploratory method to investigating technology adoption potential

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey

60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis

Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Interdisciplinary Cardiovascular and Neurologic Outpatient Rehabilitation in Patients Surviving Transient Ischemic Attack or Stroke With Minor or No Residual Deficits

The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis

Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled Trial

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

Development of a new immersive virtual reality (VR) headset-based dexterity training for patients with multiple sclerosis: Clinical and technical aspects

Behavioral Changes in Patients with Multiple Sclerosis

Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions

Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results

Relationship between Job Demands‐Resources and turnover intention in chronic disease – The example of multiple sclerosis

Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?

Hypomagnesemia-Induced Cerebellar Syndrome—A Distinct Disease Entity? Case Report and Literature Review

Tablet app-based dexterity training in multiple sclerosis (TAD-MS): a randomized controlled trial

Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries

SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology

T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter

Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry

Aktive Filter

Suchergebnisse filtern